Featured: Independent Wellness Recognized for Provider-Led GLP-1 Care in 2026 Independent Wellness Recognized for Provider-Led GLP-1 Care in 2026 Independent Wellness has been recognized as a top GLP-1 telehealth program for provider access, highlighting what truly matters in modern medical weight loss personalized care, ongoing support, and direct access to a licensed clinician
This can lead to permanent and severe neurological issues
Cardiovascular Diabetology, 23 (1), Article 299
Recent clinical guidelines increasingly recommend GLP-1RAs for patients with type 2 diabetes who have established atherosclerotic cardiovascular disease or are at high cardiovascular risk, regardless of baseline hemoglobin A1c levels
RRx-001, a novel clinical-stage chemosensitizer, radiosensitizer, and immunosensitizer, inhibits glucose 6-phosphate dehydrogenase in human tumor cells